

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 7.62514929 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.56533108 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.41949186 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.29896268 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.29896268 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.96585411 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.96585411 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.60991778 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.29174425 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.99556691 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.99556691 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.99556691 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.84566930 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.79108330 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65380487 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.63785097 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.59507490 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43734838 |
| 19 | urea metabolic process (GO:0019627) | 5.41004398 |
| 20 | urea cycle (GO:0000050) | 5.41004398 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.40320526 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.33999948 |
| 23 | cysteine metabolic process (GO:0006534) | 5.31236183 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.31039384 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.27294110 |
| 26 | protein carboxylation (GO:0018214) | 5.21659802 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.21659802 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.17078169 |
| 29 | drug metabolic process (GO:0017144) | 5.05941356 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.01869101 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.98011352 |
| 32 | bile acid metabolic process (GO:0008206) | 4.97395521 |
| 33 | regulation of complement activation (GO:0030449) | 4.96249305 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89243231 |
| 35 | ethanol metabolic process (GO:0006067) | 4.83895107 |
| 36 | oxidative demethylation (GO:0070989) | 4.82776862 |
| 37 | androgen biosynthetic process (GO:0006702) | 4.81650036 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.81512790 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.78166037 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.77147869 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.76524654 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.76086096 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.71136945 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.71136945 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.71136945 |
| 46 | lysine catabolic process (GO:0006554) | 4.63509436 |
| 47 | lysine metabolic process (GO:0006553) | 4.63509436 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.59659439 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.59299108 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.55278066 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.49869279 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.49869279 |
| 53 | phospholipid efflux (GO:0033700) | 4.47826113 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.45743215 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.45743215 |
| 56 | regulation of plasminogen activation (GO:0010755) | 4.45304046 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.42029412 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.32566574 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.31281621 |
| 60 | cellular glucuronidation (GO:0052695) | 4.28404244 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.22223368 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.21859745 |
| 63 | acute-phase response (GO:0006953) | 4.20800809 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.20015181 |
| 65 | glycine metabolic process (GO:0006544) | 4.19028535 |
| 66 | amine catabolic process (GO:0009310) | 4.17855859 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.17855859 |
| 68 | ethanol oxidation (GO:0006069) | 4.15940406 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.14744865 |
| 70 | glutamate metabolic process (GO:0006536) | 4.14735635 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 4.11062980 |
| 72 | cholesterol efflux (GO:0033344) | 4.08525663 |
| 73 | negative regulation of hemostasis (GO:1900047) | 4.07576404 |
| 74 | negative regulation of blood coagulation (GO:0030195) | 4.07576404 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 4.06799406 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.05244665 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 4.04937916 |
| 78 | drug catabolic process (GO:0042737) | 4.01321922 |
| 79 | phenylpropanoid metabolic process (GO:0009698) | 3.97917977 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95177877 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.93274724 |
| 82 | fibrinolysis (GO:0042730) | 3.90182300 |
| 83 | cellular response to cadmium ion (GO:0071276) | 3.90093506 |
| 84 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.89184547 |
| 85 | androgen metabolic process (GO:0008209) | 3.88095782 |
| 86 | serine family amino acid biosynthetic process (GO:0009070) | 3.86027382 |
| 87 | S-adenosylmethionine metabolic process (GO:0046500) | 3.84424329 |
| 88 | arginine metabolic process (GO:0006525) | 3.84267668 |
| 89 | low-density lipoprotein particle clearance (GO:0034383) | 3.83590719 |
| 90 | regulation of humoral immune response (GO:0002920) | 3.82992798 |
| 91 | adhesion of symbiont to host (GO:0044406) | 3.82919569 |
| 92 | hormone catabolic process (GO:0042447) | 3.82441482 |
| 93 | ketone body metabolic process (GO:1902224) | 3.81716931 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.81653398 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.79961818 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.79961818 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.76815011 |
| 98 | negative regulation of coagulation (GO:0050819) | 3.75541604 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.74838009 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.74128990 |
| 101 | complement activation (GO:0006956) | 3.73576186 |
| 102 | negative regulation of wound healing (GO:0061045) | 3.72312039 |
| 103 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.72139013 |
| 104 | organic acid catabolic process (GO:0016054) | 3.72038636 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.72038636 |
| 106 | blood coagulation, intrinsic pathway (GO:0007597) | 3.71994423 |
| 107 | hemoglobin metabolic process (GO:0020027) | 3.70203524 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.70085535 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.70085535 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.69688383 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68432320 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.68423487 |
| 113 | protein activation cascade (GO:0072376) | 3.67672532 |
| 114 | amyloid precursor protein catabolic process (GO:0042987) | 3.67595632 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.65850336 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.65149690 |
| 117 | steroid catabolic process (GO:0006706) | 3.63588205 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.61589465 |
| 119 | cytolysis (GO:0019835) | 3.61369510 |
| 120 | negative regulation of protein activation cascade (GO:2000258) | 3.61340479 |
| 121 | opsonization (GO:0008228) | 3.59797513 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.59661725 |
| 123 | sterol homeostasis (GO:0055092) | 3.59435570 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59163099 |
| 125 | cofactor catabolic process (GO:0051187) | 3.59155659 |
| 126 | sodium-independent organic anion transport (GO:0043252) | 3.56210871 |
| 127 | protein-lipid complex assembly (GO:0065005) | 3.52988428 |
| 128 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.43222237 |
| 129 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.43222237 |
| 130 | negative regulation of complement activation (GO:0045916) | 3.38338668 |
| 131 | positive regulation of hemostasis (GO:1900048) | 3.37982765 |
| 132 | positive regulation of blood coagulation (GO:0030194) | 3.37982765 |
| 133 | sterol catabolic process (GO:0016127) | 3.37933444 |
| 134 | cholesterol catabolic process (GO:0006707) | 3.37933444 |
| 135 | acute inflammatory response (GO:0002526) | 3.34882743 |
| 136 | regulation of triglyceride metabolic process (GO:0090207) | 3.34422851 |
| 137 | intestinal cholesterol absorption (GO:0030299) | 3.31315768 |
| 138 | drug transmembrane transport (GO:0006855) | 3.27877136 |
| 139 | alkaloid metabolic process (GO:0009820) | 3.25516270 |
| 140 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.24608219 |
| 141 | xenobiotic catabolic process (GO:0042178) | 3.20766708 |
| 142 | regulation of acute inflammatory response (GO:0002673) | 3.19506307 |
| 143 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.19056934 |
| 144 | response to mercury ion (GO:0046689) | 3.17832114 |
| 145 | detection of molecule of bacterial origin (GO:0032490) | 3.15537496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.17921691 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.99771687 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.74030426 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.36555660 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.13528984 |
| 6 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.99580581 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.89184648 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95629004 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.83627868 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.06235317 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11405125 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5618554 |
| 13 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98171427 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88353554 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79811271 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64168994 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57320564 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49564878 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42228798 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41339885 |
| 21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.39531364 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39439995 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35349555 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28659552 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22101540 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14506540 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14381210 |
| 28 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11592180 |
| 29 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08052893 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06009477 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05406247 |
| 32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01604769 |
| 33 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98858093 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97731074 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97680944 |
| 36 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97659181 |
| 37 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97144542 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95243315 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94639657 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93994493 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93129881 |
| 42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90860943 |
| 43 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89703561 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88985399 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87901921 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86767540 |
| 47 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86016498 |
| 48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85813011 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85528260 |
| 50 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85528260 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85360324 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85339754 |
| 53 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84686877 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83758262 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82579251 |
| 56 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81760324 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81116686 |
| 58 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80542195 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80305881 |
| 60 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.78768686 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78742853 |
| 62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78613031 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78566915 |
| 64 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76686670 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76109411 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75531834 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75414482 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75414482 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.72781317 |
| 70 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72386144 |
| 71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71360867 |
| 72 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71000136 |
| 73 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69282501 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68877466 |
| 75 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66852416 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.66223143 |
| 77 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65293782 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.64779221 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.64252706 |
| 80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63772890 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63387355 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62734205 |
| 83 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62595544 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62335661 |
| 85 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.61001394 |
| 86 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60452463 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 0.59345797 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57254384 |
| 89 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57231852 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57141560 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55236992 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55211207 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.54799164 |
| 94 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.54594520 |
| 95 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.54309411 |
| 96 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54047860 |
| 97 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.53846583 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.53783005 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.53678158 |
| 100 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53356631 |
| 101 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.53065118 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51742892 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.51696022 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51207247 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.50890626 |
| 106 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.50877972 |
| 107 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.50076476 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50061110 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49399658 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48963175 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48932395 |
| 112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48694387 |
| 113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46686931 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46393988 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.45672303 |
| 116 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45589882 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45520363 |
| 118 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45341324 |
| 119 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45138624 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44762485 |
| 121 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43610334 |
| 122 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42803846 |
| 123 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42437499 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41853558 |
| 125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.41678673 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40927049 |
| 127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39469002 |
| 128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.38628007 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.38546081 |
| 130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38289611 |
| 131 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38095854 |
| 132 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.37889108 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37674386 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37639986 |
| 135 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.37150946 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36645572 |
| 137 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.35841891 |
| 138 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35446738 |
| 139 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35390723 |
| 140 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.35357218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.22465563 |
| 2 | MP0005360_urolithiasis | 7.47134244 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.17263960 |
| 4 | MP0005365_abnormal_bile_salt | 5.99218243 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.21737220 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.18189590 |
| 7 | MP0008004_abnormal_stomach_pH | 3.90480589 |
| 8 | MP0003252_abnormal_bile_duct | 3.81285828 |
| 9 | * MP0010329_abnormal_lipoprotein_level | 3.49506359 |
| 10 | MP0009840_abnormal_foam_cell | 3.24490303 |
| 11 | MP0005083_abnormal_biliary_tract | 2.93290110 |
| 12 | MP0005332_abnormal_amino_acid | 2.84087600 |
| 13 | MP0003195_calcinosis | 2.63406099 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.48041344 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.33874737 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.16873445 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.12854920 |
| 18 | * MP0002118_abnormal_lipid_homeostasis | 2.08939725 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.08280424 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81539061 |
| 21 | MP0003868_abnormal_feces_composition | 1.78054651 |
| 22 | MP0001764_abnormal_homeostasis | 1.65341635 |
| 23 | MP0003279_aneurysm | 1.54984044 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.54474079 |
| 25 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.54144171 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.52522840 |
| 27 | MP0009697_abnormal_copulation | 1.52167258 |
| 28 | MP0002332_abnormal_exercise_endurance | 1.49398525 |
| 29 | MP0005451_abnormal_body_composition | 1.37761357 |
| 30 | MP0003011_delayed_dark_adaptation | 1.32801353 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.32524532 |
| 32 | MP0003186_abnormal_redox_activity | 1.32231581 |
| 33 | MP0005023_abnormal_wound_healing | 1.22830090 |
| 34 | MP0000604_amyloidosis | 1.22266512 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.17710172 |
| 36 | MP0002254_reproductive_system_inflammat | 1.16868642 |
| 37 | MP0005647_abnormal_sex_gland | 1.16117997 |
| 38 | MP0009764_decreased_sensitivity_to | 1.15741881 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.15665894 |
| 40 | MP0000598_abnormal_liver_morphology | 1.13942440 |
| 41 | MP0009763_increased_sensitivity_to | 1.04661147 |
| 42 | MP0004272_abnormal_basement_membrane | 1.02895062 |
| 43 | MP0010368_abnormal_lymphatic_system | 0.98760278 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 0.97913941 |
| 45 | MP0005670_abnormal_white_adipose | 0.97348037 |
| 46 | MP0008469_abnormal_protein_level | 0.94779861 |
| 47 | MP0002876_abnormal_thyroid_physiology | 0.88077890 |
| 48 | * MP0009642_abnormal_blood_homeostasis | 0.87285726 |
| 49 | MP0001661_extended_life_span | 0.85546706 |
| 50 | MP0004130_abnormal_muscle_cell | 0.83027315 |
| 51 | MP0002971_abnormal_brown_adipose | 0.82400239 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.81317265 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.80340568 |
| 54 | MP0004233_abnormal_muscle_weight | 0.78726652 |
| 55 | MP0003329_amyloid_beta_deposits | 0.78724841 |
| 56 | MP0003690_abnormal_glial_cell | 0.77845231 |
| 57 | MP0005375_adipose_tissue_phenotype | 0.77593622 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.77271507 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.74795967 |
| 60 | MP0005408_hypopigmentation | 0.74098154 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 0.73777100 |
| 62 | * MP0002078_abnormal_glucose_homeostasis | 0.73722366 |
| 63 | MP0004510_myositis | 0.73446513 |
| 64 | MP0001851_eye_inflammation | 0.71885501 |
| 65 | MP0001915_intracranial_hemorrhage | 0.71639928 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.71463691 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.71331161 |
| 68 | MP0005535_abnormal_body_temperature | 0.70182155 |
| 69 | MP0002896_abnormal_bone_mineralization | 0.69852112 |
| 70 | MP0008775_abnormal_heart_ventricle | 0.69412464 |
| 71 | MP0005275_abnormal_skin_tensile | 0.69182825 |
| 72 | MP0003724_increased_susceptibility_to | 0.68638427 |
| 73 | MP0002909_abnormal_adrenal_gland | 0.66828713 |
| 74 | * MP0005334_abnormal_fat_pad | 0.65054482 |
| 75 | MP0001756_abnormal_urination | 0.64995379 |
| 76 | MP0005187_abnormal_penis_morphology | 0.62415868 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.61479680 |
| 78 | MP0005464_abnormal_platelet_physiology | 0.60046299 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.59732237 |
| 80 | MP0005266_abnormal_metabolism | 0.58944146 |
| 81 | MP0003091_abnormal_cell_migration | 0.58939973 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.58886107 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.58690218 |
| 84 | MP0000343_altered_response_to | 0.57005160 |
| 85 | MP0009785_altered_susceptibility_to | 0.56350159 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.55760522 |
| 87 | MP0002933_joint_inflammation | 0.55364356 |
| 88 | MP0005448_abnormal_energy_balance | 0.54067461 |
| 89 | MP0003436_decreased_susceptibility_to | 0.52589128 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.52203409 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.52094237 |
| 92 | MP0003828_pulmonary_edema | 0.52073541 |
| 93 | MP0003075_altered_response_to | 0.51840039 |
| 94 | MP0003303_peritoneal_inflammation | 0.51233029 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.50814947 |
| 96 | MP0009053_abnormal_anal_canal | 0.50359398 |
| 97 | MP0008874_decreased_physiological_sensi | 0.49902893 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.49863056 |
| 99 | MP0006082_CNS_inflammation | 0.49764581 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.48770004 |
| 101 | MP0005395_other_phenotype | 0.45483551 |
| 102 | MP0005166_decreased_susceptibility_to | 0.44900346 |
| 103 | MP0000249_abnormal_blood_vessel | 0.44569020 |
| 104 | * MP0000639_abnormal_adrenal_gland | 0.44549926 |
| 105 | MP0002928_abnormal_bile_duct | 0.44125281 |
| 106 | MP0004883_abnormal_blood_vessel | 0.42908511 |
| 107 | MP0008873_increased_physiological_sensi | 0.42143149 |
| 108 | MP0001853_heart_inflammation | 0.41831000 |
| 109 | MP0002822_catalepsy | 0.40969626 |
| 110 | MP0009115_abnormal_fat_cell | 0.40527533 |
| 111 | * MP0003953_abnormal_hormone_level | 0.39138169 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.38866059 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.38264503 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.38101702 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.37959621 |
| 116 | MP0005164_abnormal_response_to | 0.37549825 |
| 117 | MP0002168_other_aberrant_phenotype | 0.37455431 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.36383718 |
| 119 | MP0001881_abnormal_mammary_gland | 0.36257494 |
| 120 | MP0002132_abnormal_respiratory_system | 0.35209572 |
| 121 | MP0001243_abnormal_dermal_layer | 0.34686290 |
| 122 | MP0002970_abnormal_white_adipose | 0.34280086 |
| 123 | MP0008872_abnormal_physiological_respon | 0.33532018 |
| 124 | MP0004381_abnormal_hair_follicle | 0.31629197 |
| 125 | MP0002796_impaired_skin_barrier | 0.31321182 |
| 126 | MP0003718_maternal_effect | 0.31148797 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.30697793 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.29739347 |
| 129 | MP0002060_abnormal_skin_morphology | 0.29158937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.31413917 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.12225467 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.04544272 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.36911722 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.31414338 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.19698869 |
| 7 | Xanthomatosis (HP:0000991) | 6.19311636 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.67095098 |
| 9 | Complement deficiency (HP:0004431) | 5.30418189 |
| 10 | Joint hemorrhage (HP:0005261) | 4.71966872 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.70866262 |
| 12 | Hyperammonemia (HP:0001987) | 4.58501725 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.34665312 |
| 14 | Hyperglycinemia (HP:0002154) | 4.33949759 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.33297522 |
| 16 | Epidermoid cyst (HP:0200040) | 4.33063151 |
| 17 | Ketosis (HP:0001946) | 4.27262116 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.18550517 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18501317 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18320744 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.15153472 |
| 22 | Hyperglycinuria (HP:0003108) | 4.08641840 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07133269 |
| 24 | Fat malabsorption (HP:0002630) | 3.98797646 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.98795651 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.98795651 |
| 27 | Abnormality of complement system (HP:0005339) | 3.83396350 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.82855635 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66007937 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59676234 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.56970880 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.55954558 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46439091 |
| 34 | Anomalous pulmonary venous return (HP:0010772) | 3.39622762 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38824322 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.29069890 |
| 37 | Relative macrocephaly (HP:0004482) | 3.19331568 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.12284352 |
| 39 | Ketoacidosis (HP:0001993) | 3.11910374 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07706161 |
| 41 | Steatorrhea (HP:0002570) | 3.01976331 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.98909209 |
| 43 | Abnormality of the pulmonary veins (HP:0011718) | 2.98384384 |
| 44 | Cerebral palsy (HP:0100021) | 2.98367143 |
| 45 | Myocardial infarction (HP:0001658) | 2.97434885 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.94253256 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.89136868 |
| 48 | Spontaneous abortion (HP:0005268) | 2.83890133 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.81721125 |
| 50 | Metabolic acidosis (HP:0001942) | 2.79220425 |
| 51 | Skin nodule (HP:0200036) | 2.75618907 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.73049818 |
| 53 | Vascular calcification (HP:0004934) | 2.67310531 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.66033894 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66033894 |
| 56 | Mitral stenosis (HP:0001718) | 2.62741731 |
| 57 | Osteomalacia (HP:0002749) | 2.62290149 |
| 58 | Large earlobe (HP:0009748) | 2.62276209 |
| 59 | Lethargy (HP:0001254) | 2.58422948 |
| 60 | Gout (HP:0001997) | 2.55191646 |
| 61 | Glomerulonephritis (HP:0000099) | 2.49732851 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45292490 |
| 63 | Spastic diplegia (HP:0001264) | 2.43052981 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.39232389 |
| 65 | Amyloidosis (HP:0011034) | 2.38340588 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.37474273 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.35214957 |
| 68 | Malnutrition (HP:0004395) | 2.33787795 |
| 69 | Cholelithiasis (HP:0001081) | 2.32474411 |
| 70 | Acanthocytosis (HP:0001927) | 2.31937237 |
| 71 | Esophageal varix (HP:0002040) | 2.31139163 |
| 72 | Arthropathy (HP:0003040) | 2.30049851 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.29801308 |
| 74 | Cerebral edema (HP:0002181) | 2.29379830 |
| 75 | Irritability (HP:0000737) | 2.29178746 |
| 76 | Neonatal onset (HP:0003623) | 2.29004573 |
| 77 | Neonatal hypoglycemia (HP:0001998) | 2.22967540 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.22956705 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.22769981 |
| 80 | Cholecystitis (HP:0001082) | 2.22769981 |
| 81 | Pancreatitis (HP:0001733) | 2.21611728 |
| 82 | Gingival bleeding (HP:0000225) | 2.20227871 |
| 83 | Joint swelling (HP:0001386) | 2.16767489 |
| 84 | Ureteral duplication (HP:0000073) | 2.16076412 |
| 85 | Menorrhagia (HP:0000132) | 2.14852121 |
| 86 | Vomiting (HP:0002013) | 2.14096611 |
| 87 | Abnormality of carpal bone ossification (HP:0006257) | 2.12265798 |
| 88 | Late onset (HP:0003584) | 2.11282991 |
| 89 | Thrombophlebitis (HP:0004418) | 2.10850149 |
| 90 | Enlarged kidneys (HP:0000105) | 2.09787275 |
| 91 | Diastasis recti (HP:0001540) | 2.08557588 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.06485461 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.06485461 |
| 94 | Brushfield spots (HP:0001088) | 2.05792575 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.05327764 |
| 96 | Rhizomelia (HP:0008905) | 2.03647945 |
| 97 | Purpura (HP:0000979) | 1.96984521 |
| 98 | Opisthotonus (HP:0002179) | 1.96131135 |
| 99 | Alkalosis (HP:0001948) | 1.96057190 |
| 100 | Renal cortical cysts (HP:0000803) | 1.95794823 |
| 101 | Abnormality of the gallbladder (HP:0005264) | 1.95287961 |
| 102 | Protrusio acetabuli (HP:0003179) | 1.93172944 |
| 103 | Stenosis of the external auditory canal (HP:0000402) | 1.92586028 |
| 104 | Abnormality of the Achilles tendon (HP:0005109) | 1.91863653 |
| 105 | Rickets (HP:0002748) | 1.88643989 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 1.87653943 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86159514 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.85455099 |
| 109 | Nephritis (HP:0000123) | 1.84273438 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 1.82922652 |
| 111 | Pulmonary embolism (HP:0002204) | 1.82680945 |
| 112 | Proximal tubulopathy (HP:0000114) | 1.82425030 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.82128332 |
| 114 | Poikilocytosis (HP:0004447) | 1.82007175 |
| 115 | Fair hair (HP:0002286) | 1.81888510 |
| 116 | Cervical subluxation (HP:0003308) | 1.81112563 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80994488 |
| 118 | Status epilepticus (HP:0002133) | 1.80880440 |
| 119 | Hypertriglyceridemia (HP:0002155) | 1.80067021 |
| 120 | Acute hepatic failure (HP:0006554) | 1.79615771 |
| 121 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79181920 |
| 122 | Reduced antithrombin III activity (HP:0001976) | 1.78111084 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74704297 |
| 124 | Mucopolysacchariduria (HP:0008155) | 1.74704297 |
| 125 | Hyperglycemia (HP:0003074) | 1.73047608 |
| 126 | Split foot (HP:0001839) | 1.65683246 |
| 127 | Increased serum ferritin (HP:0003281) | 1.65370292 |
| 128 | Abnormal ossification of hand bones (HP:0005921) | 1.64838522 |
| 129 | Abnormality of the alveolar ridges (HP:0006477) | 1.64557652 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.62290769 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.62290769 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.62290769 |
| 133 | Wrist flexion contracture (HP:0001239) | 1.59788625 |
| 134 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.59520988 |
| 135 | Abnormal hand bone ossification (HP:0010660) | 1.57521951 |
| 136 | Atrioventricular block (HP:0001678) | 1.56917248 |
| 137 | Hypophosphatemia (HP:0002148) | 1.53585103 |
| 138 | Partial agenesis of the corpus callosum (HP:0001338) | 1.51294235 |
| 139 | Ulnar bowing (HP:0003031) | 1.49377621 |
| 140 | Bone pain (HP:0002653) | 1.47961832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 7.71984909 |
| 2 | BCKDK | 6.82378455 |
| 3 | FGFR4 | 4.63900122 |
| 4 | SIK1 | 4.48117677 |
| 5 | ERN1 | 4.32886047 |
| 6 | DDR2 | 2.96037564 |
| 7 | TAOK3 | 2.78982523 |
| 8 | INSRR | 2.67358197 |
| 9 | TRIB3 | 2.33779986 |
| 10 | ERBB4 | 2.26705551 |
| 11 | PKN2 | 2.17704629 |
| 12 | MAP2K4 | 2.04021537 |
| 13 | MST1R | 2.01022690 |
| 14 | TYK2 | 1.88997766 |
| 15 | ARAF | 1.78064303 |
| 16 | FLT3 | 1.76589972 |
| 17 | MAPK11 | 1.76535546 |
| 18 | PIK3CG | 1.72721773 |
| 19 | EPHB2 | 1.68820615 |
| 20 | FGFR2 | 1.61080686 |
| 21 | KDR | 1.60855216 |
| 22 | LATS2 | 1.55426020 |
| 23 | KSR2 | 1.53348589 |
| 24 | DAPK2 | 1.46403058 |
| 25 | PDK2 | 1.39303332 |
| 26 | PTK6 | 1.38576303 |
| 27 | NEK9 | 1.33483988 |
| 28 | JAK1 | 1.30958575 |
| 29 | GRK6 | 1.30754232 |
| 30 | MAP3K7 | 1.26669799 |
| 31 | TIE1 | 1.26658372 |
| 32 | ABL2 | 1.26026682 |
| 33 | LATS1 | 1.25621966 |
| 34 | JAK2 | 1.23685886 |
| 35 | TGFBR2 | 1.23505114 |
| 36 | TBK1 | 1.20231353 |
| 37 | FRK | 1.18852021 |
| 38 | MAP3K14 | 1.17234239 |
| 39 | CSK | 1.14875949 |
| 40 | STK38 | 1.12357658 |
| 41 | PINK1 | 1.12261081 |
| 42 | PRKAA2 | 1.11549650 |
| 43 | MAP2K3 | 1.09677333 |
| 44 | LMTK2 | 1.06190917 |
| 45 | CAMK4 | 1.00773893 |
| 46 | MAPK12 | 1.00738215 |
| 47 | MAPK4 | 0.98352435 |
| 48 | CDC42BPA | 0.97907933 |
| 49 | EPHB1 | 0.97757081 |
| 50 | FGFR3 | 0.96291228 |
| 51 | MAP3K9 | 0.95772954 |
| 52 | AKT3 | 0.95552693 |
| 53 | IKBKE | 0.88782705 |
| 54 | ICK | 0.88438818 |
| 55 | EIF2AK3 | 0.87117889 |
| 56 | RIPK1 | 0.86722580 |
| 57 | PRKCZ | 0.86128544 |
| 58 | CAMK1D | 0.84070607 |
| 59 | MAP3K1 | 0.81382513 |
| 60 | MAP3K3 | 0.81092543 |
| 61 | PDGFRB | 0.80199320 |
| 62 | IRAK3 | 0.78484408 |
| 63 | STK38L | 0.74289784 |
| 64 | EPHA3 | 0.73460499 |
| 65 | PRKACG | 0.72539476 |
| 66 | SGK3 | 0.72172045 |
| 67 | MAP3K10 | 0.72157614 |
| 68 | MAP2K6 | 0.70045584 |
| 69 | CDK6 | 0.69389518 |
| 70 | MET | 0.68816921 |
| 71 | CAMKK2 | 0.68333051 |
| 72 | ERBB2 | 0.66001452 |
| 73 | MAPK7 | 0.64752649 |
| 74 | TESK1 | 0.64369781 |
| 75 | GSK3A | 0.64253223 |
| 76 | PRKCQ | 0.63893071 |
| 77 | MOS | 0.63647594 |
| 78 | FER | 0.63347906 |
| 79 | PDPK1 | 0.63127147 |
| 80 | PRKAA1 | 0.61825224 |
| 81 | MAP3K13 | 0.61202376 |
| 82 | NTRK1 | 0.59942183 |
| 83 | CAMK2G | 0.59668826 |
| 84 | MTOR | 0.59478763 |
| 85 | IGF1R | 0.59035125 |
| 86 | ITK | 0.57504785 |
| 87 | MAP3K2 | 0.57451502 |
| 88 | PTK2 | 0.57307424 |
| 89 | MAP3K12 | 0.56866303 |
| 90 | ZAP70 | 0.56129220 |
| 91 | MAP3K11 | 0.55808136 |
| 92 | MAPK3 | 0.55444657 |
| 93 | MYLK | 0.54763221 |
| 94 | MAP4K1 | 0.53599673 |
| 95 | GRK1 | 0.52159843 |
| 96 | EPHA4 | 0.51966979 |
| 97 | NTRK3 | 0.51936217 |
| 98 | RAF1 | 0.51926351 |
| 99 | TAOK2 | 0.50612872 |
| 100 | MAPK15 | 0.50503939 |
| 101 | PIM2 | 0.50185332 |
| 102 | CSF1R | 0.49992062 |
| 103 | SGK2 | 0.49772250 |
| 104 | MELK | 0.48914289 |
| 105 | KSR1 | 0.46313723 |
| 106 | DYRK1B | 0.45075611 |
| 107 | PDK1 | 0.44825678 |
| 108 | PDK4 | 0.43587439 |
| 109 | PDK3 | 0.43587439 |
| 110 | MAP2K2 | 0.43076122 |
| 111 | LRRK2 | 0.39144998 |
| 112 | ROCK1 | 0.38517037 |
| 113 | RET | 0.37870637 |
| 114 | JAK3 | 0.36762713 |
| 115 | PAK2 | 0.35991885 |
| 116 | MAP3K6 | 0.35858548 |
| 117 | CAMK1G | 0.35282125 |
| 118 | MAP2K1 | 0.34936070 |
| 119 | PRKCH | 0.34836033 |
| 120 | PRKACA | 0.34412358 |
| 121 | PRKCG | 0.34233964 |
| 122 | MAPK1 | 0.33915738 |
| 123 | SGK494 | 0.33752505 |
| 124 | SGK223 | 0.33752505 |
| 125 | STK24 | 0.33468176 |
| 126 | EGFR | 0.33430482 |
| 127 | BLK | 0.33087325 |
| 128 | PDGFRA | 0.33057224 |
| 129 | MAP3K5 | 0.32589357 |
| 130 | FGFR1 | 0.32202374 |
| 131 | PRKD2 | 0.32139256 |
| 132 | ROCK2 | 0.31354900 |
| 133 | KIT | 0.31163413 |
| 134 | CDK4 | 0.30908855 |
| 135 | AKT2 | 0.30782748 |
| 136 | SRC | 0.30755710 |
| 137 | MAPKAPK3 | 0.29685643 |
| 138 | RPS6KA5 | 0.29002634 |
| 139 | CSNK1G1 | 0.27773659 |
| 140 | PRKCA | 0.27493438 |
| 141 | NLK | 0.25746999 |
| 142 | ABL1 | 0.25235535 |
| 143 | BMX | 0.24678278 |
| 144 | IRAK1 | 0.24566345 |
| 145 | TXK | 0.23998001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42128237 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59737788 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40471364 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21521087 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97156755 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74933370 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74442083 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71379438 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63502891 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57035576 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46344495 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45737698 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29758544 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16799282 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16312259 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.11494340 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04116241 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94293851 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91859976 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90557017 |
| 21 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87339849 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86766306 |
| 23 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84576434 |
| 24 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82710763 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81169369 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75691790 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75675728 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73957641 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66445074 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65277360 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60298130 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53106584 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52538734 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.52405964 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51691469 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41123274 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38321946 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37373934 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36043524 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33438026 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31057450 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22149916 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.20617051 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16474328 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15418554 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14448072 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11541190 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10922926 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04878350 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03390425 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97429986 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95899409 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95151419 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92912026 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92166269 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88054681 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87354989 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85299854 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82866196 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.80644573 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75293219 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70503002 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69410335 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66984061 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65775515 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60934354 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56225265 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44058164 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.36569503 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33193431 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31573027 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.31405935 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26635965 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26548494 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.25422169 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.25333320 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25257151 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21916534 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17624436 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16326094 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.13594242 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10156544 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08495152 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.06851828 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03608568 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01904837 |
| 87 | Malaria_Homo sapiens_hsa05144 | -0.2412974 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2363207 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2274452 |
| 90 | Pertussis_Homo sapiens_hsa05133 | -0.2171114 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | -0.2088398 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2017784 |
| 93 | Lysosome_Homo sapiens_hsa04142 | -0.1962165 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1670476 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1660526 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1611513 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1532545 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1392816 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1360506 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1263019 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1215436 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1192812 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1164677 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.1127803 |
| 105 | Phagosome_Homo sapiens_hsa04145 | -0.1048036 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0963303 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0864733 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0840577 |
| 109 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0614701 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0480152 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0416930 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0371303 |

